期刊文献+

快速稳定性分析方法研究增稠剂对丙泊酚乳状注射液稳定性的影响 被引量:1

Study on Effect of Thickening Agents on the Stability of Propofol Emulsion Injection by Rapid Stability Analysis Instrument
原文传递
导出
摘要 目的考察增稠剂对丙泊酚乳状注射液稳定性的影响。方法选用快速稳定性分析仪LUMiSizer,结合静置观察、离心沉淀率测定、平均粒径和Zeta电位测定的方法考察3种增稠剂——羧甲基纤维素钠、透明质酸、羧甲基壳聚糖的不同添加量对丙泊酚乳状注射液稳定性的影响。结果羧甲基纤维素钠和羧甲基壳聚糖容易造成乳液的絮集沉淀,透明质酸在0.02%~0.1%用量下具有良好的悬浮稳定效果。结论透明质酸通过形成的网状结构可以减少乳液中组分的沉降速度,对丙泊酚乳状注射液的稳定性有明显的提高作用。 OBJECTIVE To investigate the effect of thickening agents on the stability of propofol emulsion injection.METHODS The influence of three kinds of thickening agents including sodium carboxymethyl cellulose,hyaluronic acid,carboxymethyl chitosan amount on the stability of propofol emulsion injection were investigated by rapid stability analysis instrument LUMiSizer,combined with standing observation,centrifugal precipitation,average particle size,and Zeta potential.RESULTS Sodium carboxymethyl cellulose and carboxymethyl chitosan were easy to cause flocculation and sediment of emulsion,but good inhibition effect of sedimentation with 0.02%–0.1%of hyaluronic acid.CONCLUSION Hyaluronic acid can reduce the sedimentation rate of components in the emulsion by forming a reticular structure,and significantly improves the stability of propofol emulsion injection.
作者 贺周扬 王琴 郭秀彩 李闫飞 吴艳华 蔡文坚 岳峰 HE Zhouyang;WANG Qin;GUO Xiucai;LI Yanfei;WU Yanhua;CAI Wenjian;YUE Feng(Guangdong Jiabo Pharmaceutical Co.,Ltd.,Qingyuan 511500,China;Guangzhou Twelfth Peoples’s Hospital,Guangzhou 510620,China)
出处 《中国现代应用药学》 CAS CSCD 北大核心 2021年第11期1358-1362,共5页 Chinese Journal of Modern Applied Pharmacy
关键词 增稠剂 稳定性分析 LUMiSizer 丙泊酚 thickening agent stability analysis LUMiSizer propofol
  • 相关文献

参考文献10

二级参考文献72

  • 1罗瑞昌,王思玲,周晓堂,姜同英,苏德森.复方异丙酚静脉亚微乳的制备及理化性质考察[J].中国药剂学杂志(网络版),2008(2):30-35. 被引量:3
  • 2迟文,张昌斌,曹永红,郭凌燕.限制5-羟甲基糠醛生成条件的探讨[J].解放军药学学报,1998,14(2):101-104. 被引量:14
  • 3郭涛,储晓琴,何进,孙学惠,宋洪涛,邓意辉.大蒜油亚微乳的稳定性研究[J].解放军药学学报,2005,21(2):81-84. 被引量:12
  • 4Ryoo H K,Park C W,Chi S C,et al.Development of propofol-loaded microemulsion systems for parenteral delivery.Arch Pharm Res,2005,28(12):1400. 被引量:1
  • 5Floyd A G.Top ten considerations in the development of parenteral emulsions.Pharma Sci Technolo Today,1999,4 (2):134. 被引量:1
  • 6Sato N,Deckelbaum R J,Neeser G,et al.Hydrolysis of mixed lipid emulsions containing medium-chain and long-chain triacylglycerol with lipoprotein lipase in plasma-like medium.JPEN J Parenter Enteral Nutr,1994,18(2):112. 被引量:1
  • 7Ohmizo H,Obara S,Iwama H.Mechanism of injection pain with long and long-medium chain triglyceride emusive propofol.Can J Anaesth,2005,52(6):595. 被引量:1
  • 8Jumaa M,Muller B W.In vitro investigation of the effect of various isotonic substances in parenteral emulsions on human erythrocytes.Eur J Pharm Sci,1999,9(2):207. 被引量:1
  • 9Burgess D J.Injectable Dispersed Systems:Formulation,Processing,and Performance.Taylor and Francis Group,LLC,2005:424. 被引量:1
  • 10Hara M,Kai Y,Ikemoto Y.Enhancement by propofol of the gamma-aminobutyric acid A response in dissociated hippoeampal pyramidal neurons of the rat.Anesthesiology,1994,81:988-994. 被引量:1

共引文献209

同被引文献18

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部